Company Profiles

driven by the PitchBook Platform

PanOptica

PanOptica
2009 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series B LATEST DEAL TYPE
$11M LATEST DEAL AMOUNT
$86M TOTAL AMOUNT RAISED
Description

Provider of therapies for sight-threatening diseases. The company offers therapies for the treatment of suffer debilitating vision loss, age-related muscular degeneration and diabetic retinopathy.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
150 Morristown Road
Suite 205
Bernardsville, NJ 07924-2626
United States
+1 (908) 766-2202
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PanOptica’s full profile, request a free trial.

PanOptica Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 06-Oct-2017 $11M $86M Completed Generating Revenue
2. Early Stage VC (Series B) 15-Apr-2014 0000 0000 0000 Completed Startup
1. Early Stage VC (Series A) 22-Feb-2012 $30M $30M $48M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

PanOptica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

PanOptica Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
SV Health Investors Venture Capital Minority 000 0000 000000 0
Third Rock Ventures Venture Capital Minority 000 0000 000000 0

PanOptica Executive Team (5)

Name Title Board
Seat
Contact
Info
Paul Chaney Board Member, Co-Founder, President & Chief Executive Officer
Lori Forrest Executive Director, Finance & Controller
Kristine Curtiss Executive Director, Clinical Operations
Martin Wax MD Co-Founder, Chief Medical Officer & Executive Vice President, Research & Development
David Bingaman Ph.D Senior Director, Clinical Development

PanOptica Board Members (8)

Name Representing Role Since Contact
Info
Bruce Peacock SV Health Investors Board Member 000 0000
Colin Goddard Ph.D Self Board Member 000 0000
David Guyer MD SV Health Investors Chairman 000 0000
Kevin Starr Third Rock Ventures Board Member 000 0000
Thomas Dyrberg MD Novo Holdings Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »